chr6-41916806-C-T

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_004275.5(MED20):​c.148G>A​(p.Ala50Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00113 in 1,614,014 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A50S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00078 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0012 ( 0 hom. )

Consequence

MED20
NM_004275.5 missense

Scores

3
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.02

Publications

9 publications found
Variant links:
Genes affected
MED20 (HGNC:16840): (mediator complex subunit 20) This gene encodes a component of the mediator complex (also known as TRAP, SMCC, DRIP, or ARC), a transcriptional coactivator complex thought to be required for the expression of almost all genes. The mediator complex is recruited by transcriptional activators or nuclear receptors to induce gene expression, by interacting with RNA polymerase II and promoting the formation of a transcriptional pre-initiation complex. A mutation in this gene has been associated with a novel infantile-onset neurodegenerative movement disorder. Alternatively spliced transcript variants have been identified. [provided by RefSeq, Mar 2015]
BYSL (HGNC:1157): (bystin like) Bystin is expressed as a 2-kb major transcript and a 3.6-kb minor transcript in SNG-M cells and in human trophoblastic teratocarcinoma HT-H cells. Protein binding assays determined that bystin binds directly to trophinin and tastin, and that binding is enhanced when cytokeratins 8 and 18 are present. Immunocytochemistry of HT-H cells showed that bystin colocalizes with trophinin, tastin, and the cytokeratins, suggesting that these molecules form a complex in trophectoderm cells at the time of implantation. Using immunohistochemistry it was determined that trophinin and bystin are found in the placenta from the sixth week of pregnancy. Both proteins were localized in the cytoplasm of the syncytiotrophoblast in the chorionic villi and in endometrial decidual cells at the uteroplacental interface. After week 10, the levels of trophinin, tastin, and bystin decreased and then disappeared from placental villi. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.025152504).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004275.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MED20
NM_004275.5
MANE Select
c.148G>Ap.Ala50Thr
missense
Exon 2 of 4NP_004266.2
MED20
NM_001305457.2
c.148G>Ap.Ala50Thr
missense
Exon 2 of 4NP_001292386.1Q9H944-2
MED20
NM_001305456.2
c.-155G>A
5_prime_UTR
Exon 2 of 5NP_001292385.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MED20
ENST00000265350.9
TSL:1 MANE Select
c.148G>Ap.Ala50Thr
missense
Exon 2 of 4ENSP00000265350.4Q9H944-1
ENSG00000288721
ENST00000684631.1
n.148G>A
non_coding_transcript_exon
Exon 2 of 10ENSP00000507261.1
MED20
ENST00000953440.1
c.148G>Ap.Ala50Thr
missense
Exon 2 of 5ENSP00000623499.1

Frequencies

GnomAD3 genomes
AF:
0.000769
AC:
117
AN:
152124
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000604
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00160
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00107
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000656
AC:
165
AN:
251462
AF XY:
0.000625
show subpopulations
Gnomad AFR exome
AF:
0.000431
Gnomad AMR exome
AF:
0.000116
Gnomad ASJ exome
AF:
0.0000992
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000832
Gnomad NFE exome
AF:
0.00115
Gnomad OTH exome
AF:
0.000652
GnomAD4 exome
AF:
0.00116
AC:
1702
AN:
1461772
Hom.:
0
Cov.:
30
AF XY:
0.00112
AC XY:
814
AN XY:
727188
show subpopulations
African (AFR)
AF:
0.000239
AC:
8
AN:
33480
American (AMR)
AF:
0.000201
AC:
9
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86252
European-Finnish (FIN)
AF:
0.000936
AC:
50
AN:
53406
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00144
AC:
1600
AN:
1111926
Other (OTH)
AF:
0.000563
AC:
34
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
94
188
283
377
471
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
62
124
186
248
310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000775
AC:
118
AN:
152242
Hom.:
0
Cov.:
32
AF XY:
0.000860
AC XY:
64
AN XY:
74448
show subpopulations
African (AFR)
AF:
0.000626
AC:
26
AN:
41542
American (AMR)
AF:
0.0000654
AC:
1
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00160
AC:
17
AN:
10606
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00107
AC:
73
AN:
68010
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
6
12
18
24
30
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000333
Hom.:
0
Bravo
AF:
0.000608
TwinsUK
AF:
0.00135
AC:
5
ALSPAC
AF:
0.00104
AC:
4
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00163
AC:
14
ExAC
AF:
0.000667
AC:
81
EpiCase
AF:
0.000927
EpiControl
AF:
0.00119

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.077
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.31
CADD
Benign
17
DANN
Benign
0.89
DEOGEN2
Benign
0.038
T
Eigen
Benign
-0.45
Eigen_PC
Benign
-0.35
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Uncertain
0.87
D
M_CAP
Benign
0.0091
T
MetaRNN
Benign
0.025
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.2
L
PhyloP100
1.0
PrimateAI
Uncertain
0.57
T
PROVEAN
Benign
0.050
N
REVEL
Benign
0.067
Sift
Benign
0.41
T
Sift4G
Benign
0.32
T
Polyphen
0.21
B
Vest4
0.21
MVP
0.16
MPC
0.37
ClinPred
0.0087
T
GERP RS
3.6
Varity_R
0.10
gMVP
0.34
Mutation Taster
=79/21
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs140526856; hg19: chr6-41884544; COSMIC: COSV54826320; COSMIC: COSV54826320; API